Objective To explore the influencing factors of hypertensive cerebral hemorrhage in 68 patients with supratentorial prognosis of recovery of neurological function.Methods Clinical data of 68 patients with high blood pressure treatment supratentorial intracerebral hemorrhage,and brain CT,laboratory data were retrospectively analyzed.Neurological functions and related indicators change of were daalyzed by univariate and multivariate Logistic regression analysis.Results Gender,systolic blood pressure,diastolic blood pressure,red blood cell count,such as the impact on the prognosis was not statistically significant(all P ＞ 0.05) ; median line offset,nosocomial infections,surgery,gastrointestinal bleeding,heart failure,treatment Barthel index(BI) were a significant influence on the prognosis (all P ＜ 0.01).The median line offset,nosocomial infections,bleeding,gastrointestinal bleeding,heart failure,BI integration were the main factors affecting the prognosis of neurological function recovery.Conclusion The factors which affects nerve function recovery is an important part of improving neurological outcomes.We should emphasize them.

Objective To explore the relevant factors influencing the prognosis of progressive cerebral infarction,in order to provide basis for clinical trentment and improve the prognosis of patients.Methods Clinical data of 163 patients admitted as progressive cerebral infarction and 355 patients admitted as non-progressive cerebral infarction were retrospectively analyzed.All patients were followed up by interview or telephone at the time of 30 and 90days,the clinical data were recorded.The relevant factors influencing the prognosis of progressive cerebral infarction were analyzed.Results Multiple linear regression analysis of patients with progressive cerebral infarction showed that total anterior circulation infarcts,respiratory infection,coronary heart disease history,imbalance of water and electrolyte,white blood cell increasing were leading influence risk factors for the higher National Institutes of Health Stroke Scale(NIHSS) in hospitalized patients.Analysis of patients with progressive cerebral infarction showed that total anterior circulation infarcts,lack of physical activity,NIHSS at admitting,the elderly and respiratory infection were leading influence risk factors of the higher Activities of Daily Living(ADL) and modify Rankin Scale(mRS) scores at 30d and 90d of following up.The scores of ADL and mRS at 30d and 90d were significantly higher in progressive cerebral infarction than those of non-progressive cerebral infarction patients (t =6.6179,P =0.000,t =5.2788,P =0.000,t =5.0608,P =0.000,t =4.0725,P =0.000,respectively).The recurrence of cerebral infarction in progressive cerebral infarction group and death events at 30d were also significantly higher than that of non-progressive cerebral infarction(x2 =8.423,P =0.004 and x2 =5.135,P =0.023,respectively).But the recurrence of progressive cerebral infarction and death events at 90d,there were no significant differences between progressive cerebral infarction and non-progressive cerebral infarction (x2 =1.938,P =0.159 and x2 =3.518,P =0.061,respectively).Conclusion The relevant factors influencing the prognosis of progressive cerebral infarction are common effect of various factors.In the treatment of progressive cerebral infarction should be actively considered as much as possible to improve the prognosis of patients.

Objective To explore the effect of Azithromycin on the immune mechanisms through the IL - 23 /IL - 17 axis way by observing the changes in serum levels of IL - 23,IL - 17 in rats with Adriamycin - induced nephro-sis. Methods A total of 135 rats were randomly divided into control group,model group,Azithromycin intervention group,Prednisone intervention group and united intervention group. The model was induced through a tail intravenous injection of Adriamycin for 2 times. Nine rats were randomly selected from every group to detect blood and urinary bio-chemistry,and to observe the changes of the serum levels of IL - 23,IL - 17 by enzyme - linked immunosorbent assay in 4,6,and 8 weeks. Results Compared with the model group in the 8th week,the levels of 24 - hour urinary protein [model group(354. 83 ± 70. 87)mg/ d,Azithromycin intervention group(94. 59 ± 22. 67)mg/ d,Prenisone intervention group(65. 64 ± 8. 71)mg/ d,united intervention group(47. 44 ± 9. 56)mg/ d],cholesterol[ model group(8. 71 ± 1. 60)mmol/ L,Azithromycin intervention group(3. 54 ± 0. 30)mmol/ L,Prenisone intervention group(3. 10 ± 0. 18) mmol/ L,united intervention group(2. 56 ± 0. 40)mmol/ L]were reduced significantly,while the levels of albumin [model group(16. 77 ± 3. 15)g/ L,Azithromycin intervention group(33. 82 ± 1. 16)g/ L,Prenisone intervention group (37. 80 ± 2. 73)g/ L,united intervention group(40. 78 ± 2. 63)g/ L]were increased obviously in the intervention groups,and the differences were statistically significant(F = 152. 243,99. 838,155. 836,all P ﹤ 0. 05). The serum levels of IL - 23[model group(29. 60 ± 3. 97)ng/ L,Azithromycin intervention group(29. 61 ± 2. 62)ng/ L,Prenisone intervention group(29. 74 ± 2. 23)ng/ L,united intervention group(30. 31 ± 2. 20)ng/ L],IL - 17[ model group (22. 38 ± 2. 51)ng/ L,Azithromycin intervention group(21. 97 ± 1. 89)ng/ L,Prenisone intervention group(21. 43 ± 2. 42)ng/ L,united intervention group(21. 51 ± 2. 07)ng/ L]in the model group and 3 intervention groups were higher than the control group[(17. 35 ± 3. 01)ng/ L,(14. 03 ± 2. 42)ng/ L]in the 4th week,and there were significant differences(F = 33. 819,21. 373,all P ﹤ 0. 05);and the levels of IL - 23[in the 6th week,Azithromycin intervention group(27. 20 ± 1. 71)ng/ L,Prenisone intervention group(24. 39 ± 2. 06)ng/ L,united intervention group(21. 41 ± 1. 71)ng/ L,model group(35. 78 ± 3. 21)ng/ L;in the 8th week,Azithromycin intervention group(24. 60 ± 2. 91) ng/ L,Prenisone intervention group(21. 01 ± 1. 02)ng/ L,united intervention group(18. 93 ± 1. 35)ng/ L,model group (44. 47 ± 7. 84)ng/ L],IL - 17[in the 6th week,Azithromycin intervention group(19. 12 ± 0. 37)ng/ L,Prenidone in-tervention group(18. 54 ± 0. 36)ng/ L,united intervention group(17. 57 ± 0. 42)ng/ L,model group(26. 69 ± 3. 70) ng/ L;in the 8th week,Azithromycin intervention group(17. 44 ± 0. 46)ng/ L,Prenidone intervention group(16. 37 ± 0. 49)ng/ L,united intervention group(14. 71 ± 0. 99)ng/ L,model group(34. 03 ± 3. 45)ng/ L]in the 3 intervention groups were significantly lower than those of the model group in the 6th ,8th week(F = 82. 963,44. 659 in the 6th week, F = 75. 085,200. 383 in the 8th week,all P ﹤ 0. 05). The levels of IL - 23,IL - 17 in united intervention group were lower than those in respective intervention groups(P ﹤ 0. 05),and the levels in Prednisone intervention group were lower than those in Azithromycin intervention group(P ﹤ 0. 05). Conclusions IL - 23 / IL - 17 axis' high activity may be one of the immunologic mechanisms of Adriamycin - induced nephrosis. Azithromycin may inhibit the high activity of IL - 23 / IL - 17 axis to relieve the Adriamycin - induced nephrosis. The inhibition on IL - 23 / IL - 17 axis of Azithro-mycin was similar to Prednisone,and Azithromycin may enhance the effectiveness of Prednisone.

Objective: To study the antifungal activity of triazole alcohols by introducing N-butyl and substituted benzyl as side chain. Methods: Fourteen title compounds were synthesized and characterized by 1H NMR, IR, and LC-MS. The MICs of the compounds were determined by in vitro test using 8 clinical pathogenic fungi. Results: The title compounds exhibited potent antifungal activities against nearly all fungi tested (except for Aspergillus fumigatus), especially for the deep infection ones. Compounds 6a, 6d, and 6j showed a 16-fold activity (with a MIC80 value of 0.0156 μg/ml) as that of fluconazole against Microsporum gypseum. Compounds 6m and 6n showed a 128-fold activity (with a MIC80 value of 0.0039 μg/ml) as that of fluconazole against Candida albicans, and their activities were higher than those of other positive controls. Conclusion: The title compounds with N-butyl and substituted benzyl all have antifungal activities.

The current drug non-clinical safety evalua-tion has been highly systematized and standardized, but the standard toxicology model is still some inade-quacies, need to consider other animal models of safety evaluation. This paper will expound the need of animal disease models using in safety evaluation from the as-pect of scientific theories, data requirements and the need of clinical. Then recognizing on the perspective of drug regulatory agencies to explore the feasibility of u-sing animal disease models for safety evaluation and the deficiencies, in order to predict as accurately as possi-ble of the adverse drug reactions in clinical, applied to reduce the risk of clinical patients ( patients benefit ) , and reduce the risk of drug development failures ( pharmaceutical companies benefit ) . All in all we should attach great importance to the applications of animal disease models in non-clinical safety evalua-tion.

Acrylonitrile ; toxicity ; Animals ; Male ; Mice ; Mice, Inbred Strains ; Testis ; drug effects ; pathology

Berberine is the major component of Coptidis Rhizoma and it has been used as anti-infection, anti-inflammation drug for gastrointestinal diseases. In recent years, evidence showed that it could regulate glucose and lipid metabolism. Moreover, its activity had been tested by clinical trials and animal researches. The mechanisms of berberine in diabetes include: improving the function of beta-cell; prompting insulin secretion and islets regeneration, lowing lipid level, regulating glucose and lipid metabolic by influence transcriptional factors expression such as PPARgamma, C/EBPalpha, SREBP-1c, LXR, having the activities of anti-oxidation and inhibiting reductase to repress oxidative stress state and regulate metabolic signal pathway. Although numbers of data supported that berberine could improving insulin resistance by clinical trials and animal studies, the large scale, multicenter clinical trials are needed to evaluate the effects of berberine for diabetes and its complications in the time of evidence-based medicine.
Animals ; Berberine ; adverse effects ; therapeutic use ; Diabetes Mellitus, Type 2 ; drug therapy ; genetics ; metabolism ; Glucose ; metabolism ; Humans ; Hypoglycemic Agents ; adverse effects ; therapeutic use ; Insulin ; metabolism ; Lipid Metabolism ; drug effects

OBJECTIVE: To investigate the influence of UV-B induction on the content of secondary metabolites, three kinds of alkaloid especially, in post-harvest leaves of Mahonia bealei (Fort.) Carr.. METHODS: The HPLC chromatograms of secondary metabolites in leaves before and after UV-B induction were established, and the content changes of secondary metabolites were obtained by means of comparison and analysis. RESULTS: In comparison with the control group, the contents of the secondary metabolites after UV-B induction changed dramatically. The contents of jatrorrhizine and palmatine increased obviously and reached a plateau after UVB induction for six hours. The amplification of jatrorrhizine was 410.84% and that of palmatine reached 118.76%, but the content of berberine decreased obviously after induction. CONCLUSION: UV-B induction has remarkable effects on accumulation of secondary metabolites in postharvest leaves of Mahonia bealei (Fort.) Carr.

AlM: To compare the anterior segment measurements derived from optical low coherence reflectometer ( Lenstar LS900 ) and combined Scheimpflug - Placido disk topographer ( Sirius) .
METHODS: ln this study, we enrolled healthy myopic subjects 54 ( 87 eyes ) . The central corneal thickness (CCT), anterior chamber depth (ACD), flat keratometry ( FK) readings , steep keratometry ( SK ) readings and white to white ( WTW ) were measured by LS900 and Sirius. Evaluation and analysis were performed using paired t tests, the Pearson correlation, and Bland-Altman analyses.
RESULTS: The CCT and ACD measurements were significantly lower whereas FK, SK and WTW measurements were higher with LS900 (P<0. 001). Mean differences were -6. 11 ± 6. 32μm,-0. 09 ± 0. 07mm, 0. 18 ± 0. 25D, 0. 21 ± 0. 36D and 0. 25 ± 0. 39mm with statistical significant (P<0. 01). Pearson correlation analysis showed high correlation between the 2 devices for all measurements (P<0. 001). On Bland-Altman analysis, 95% limits of agreement for all measurements were 6. 26 to -18. 49μm; 0. 04 to 0. 22mm; 0. 68 to 0. 32D; 0. 92 to 0. 50D and 1. 00 to 0. 5mm.
CONCLUSlON: Anterior segment parameters evaluated with LS900 and Sirius systemare correlated well and achieve good agreement. However, there are significantly statistical differences which may be caused by the different measurement modes, so they may not be interchangeable use under certain clinical circumstances.